Project Grant RF1NS132673
Award Date
8/21/23
Completion Date
7/31/26
Dollars Obligated
$2.3M
Funding Federal Agency
National Institute on Aging
Awarding Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This Project Grant award of $231,000.00 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), will support research to build capacity for providing culturally-tailored palliative care to underserved Black and Hispanic communities affected by Parkinson's disease, Lewy body dementia, and related disorders. The key objectives are to: 1) strengthen academic-community...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $584,820 to support a 5-year research study led by Dr. Whitley Aamodt at the University of Pennsylvania. The goal is to improve end-of-life (EOL) care quality for hospitalized patients with Lewy body disorders, a type of Alzheimer's disease and related dementia (ADRD). The project has two key objectives: 1) develop a risk prediction model to identify patients at high risk of 6-month mortality,...
This five-year, $3,732,394 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) supports a cluster randomized trial to evaluate the effectiveness of the "Palliative Care Education in Assisted Living for Dementia Care Providers" (PCEAL-DCP) intervention. The intervention aims to improve dementia care quality outcomes, including increased documentation of advance care planning discussions and hospice admissions, among 30 assisted living communities...
This $7,704,350 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to discover and develop new therapeutic strategies to delay or prevent dementia in Lewy body disorders (LBD). The grant supports a multi-project center at the University of Pennsylvania that investigates mechanisms underlying the heterogeneity of cognitive outcomes in synucleinopathies, which include conditions like Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This Project Grant award of $2,278,636.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund research to characterize and evaluate different nursing home clinician care models for residents with Alzheimer's disease and related dementias (ADRD). The project aims to understand the characteristics and outcomes of existing clinician care models, with a focus on the degree of co-management between nurse practitioners and physicians. The research will survey a nationally...
The National Institute on Aging (NIA) awarded a Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to the University of Oklahoma Health Sciences Center to examine end-of-life care for persons living with dementia (PLWD). The $2,303,477 grant will leverage data from the Dementia Care Study (D-CARE), a 4-site randomized clinical trial, to compare documentation of PLWD advance care preferences, overall end-of-life care quality, and healthcare utilization in the last 6 months...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to study the impact of hospice care on the well-being of Alzheimer's disease (AD) patients and their family members. The $318,416 project will leverage natural experiments from the opening of new hospice facilities to estimate the effects of hospice utilization on patient outcomes such as pain management, depression, and activities of daily living. It will...
This federal Project Grant award, funded by the National Institute on Aging under CFDA program 93.866 Aging Research, aims to develop and pilot a patient decision aid to support shared decision-making between clinicians, patients, and caregivers regarding pharmacologic therapies for dementia. The $234,000 grant will be awarded to the University of Colorado-Denver and has a project period from September 2024 to August 2026. The key products and services to be delivered through this grant include:...
This National Institute on Aging (NIA) Project Grant award under the Aging Research federal grant program (CFDA 93.866) provides $148,050 in funding to The Trustees of the University of Pennsylvania to conduct a qualitative descriptive study on improving the inclusion of family caregivers during hospitalization of persons living with dementia (PLWD). The study aims to: 1) describe the concept of "dementia friendly" in the hospital setting, 2) examine how family caregivers of PLWD are...